Diabetes Care
suPAR Identifies Treatment-Resistant Inflammatory Risk Beyond hs-CRP in Type 2 Diabetes With Coronary Artery Disease: An Ancillary Analysis of BARI 2D
Trial in peopleBiomarkers
The paper
The University of Texas Medical Branch at Galveston; University of Michigan
Diabetes Care, 11 Aug 2026
